115972 ⎘
Transferases transferring phosphorus-containing groups (2.7); Nucleotidyltransferases (2.7.7) RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
METHODS, COMPOSITIONS, AND KITS FOR DETERMINING THE LOCATION OF AN ANALYTE IN A BIOLOGICAL SAMPLE
#2GENE EDITING SYSTEMS COMPRISING REVERSE TRANSCRIPTASES
#3FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#4Method for Editing Bovine Gene Based on Pro-iCHI
#5GENE EDITING SYSTEMS COMPRISING REVERSE TRANSCRIPTASES
#6Engineered Integration Enzymes and Uses Thereof
#7CHROMATOGRAPHY-BASED MULTIPLEX NUCLEIC ACID DETECTOR, DETECTION TEST STRIP AND DETECTION METHOD
#8Prime Editing Systems having pegRNA with Reduced Auto-inhibitory Interaction
#9RECOMBINANT TERT-ENCODING VIRAL GENOMES AND VECTORS
#10Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same
#11Compositions and Methods for Selectively Synthesizing Triple-indexed cDNA Libraries
#12COMPOSITIONS AND METHODS FOR PRECISE EDITING OF HUMAN DYSTROPHIN
#13COMPOSITIONS COMPRISING MODIFIED, TRUNCATED GLCNAC-1-PHOSPHOTRANSFERASE
#14METHOD AND DEVICE FOR PREDICTING PRIME EDITING EFFICIENCY OF VARIOUS PRIME EDITORS IN DIFFERENT CELL TYPES
#15METHOD TO ANALYZE tRNA USING DIRECT SEQUENCING
#16COMPOSITIONS AND METHODS FOR REDUCING RNA LEVELS
#17Compositions for cDNA Synthesis and Transcriptome Profiling and Methods of Use Thereof
#18Genome Editing Compositions and Methods for Treatment of Friedreich's Ataxia
#19ENGINEERED RETRONS AND METHODS OF USE
#20SELECTIVE FUNCTIONAL ENHANCEMENT OF STEM CELLS AND OR THEIR GENETIC MATERIAL, WITH GENE TRANSFECTION FOR SHORT-AND LONG-TERM TREATMENT OF AGE-RELATED DISEASE STATES
#21LENTIVIRUS WITH ALTERED INTEGRASE ACTIVITY
#22METHOD FOR PREPARING LINEAR CLOSED DNA AND PLASMID FOR USE IN THE METHOD
#23Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes
#24METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY IN CRISPR-ASSOCIATED GENES
#25Methods of Preparing Normalised Nucleic Acid Samples, Kits and Devices for Use in the Method
#26Single Construct Platform for Simultaneous Delivery of Gene Editing Machinery and Nucleic Acid Cargo
#27ENGINEERED PROTEINS AND METHODS OF USE THEREOF
#28RECOMBINANT PROTEINS FOR GENE DELIVERY AND INSERTION
#29High throughput prime editing screens identify functional DNA variants in the human genome
#30PRIME EDITING-MEDIATED READTHROUGH OF PREMATURE TERMINATION CODONS (PERT)
#31REVERSE TRANSCRIPTASE FOR NUCLEIC ACID SEQUENCING
#32REVERSE TRANSCRIPTASE VARIANTS
#33BST POLYMERASES WITH REVERSE TRANSCRIPTASE ACTIVITY
#34SYSTEM AND METHODS FOR DUPLICATING TARGET FRAGMENTS
#35RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE
#36PRIME EDITING OF SINGLE BASE MUTATIONS IN ALPHA-1 ANTITRYPSIN DEFICIENCY
#37EDITING OF DOUBLE-STRANDED DNA WITH RELAXED PAM REQUIREMENT
#38GENOME EDITING IN PLANTS USING CAS12A NUCLEASES
#39TRANSCRIPTIONALLY RECORDING CELL COMPOSITION AND METHOD FOR NON-INVASIVE ASSESSMENT OF GUT FUNCTION
#40PRIME EDITOR VARIANTS, CONSTRUCTS, AND METHODS FOR ENHANCING PRIME EDITING EFFICIENCY AND PRECISION
#41GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FUCHS ENDOTHELIAL CORNEAL DYSTROPHY
#42Cancer Vaccines and Methods of Treatment Using The Same
#43DNA APTAMERS FOR INHIBITING REVERSE TRANSCRIPTASES
#44METHODS AND COMPOSITIONS FOR INHIBITING MISMATCH REPAIR
#45MODIFIED PRIME EDITING GUIDE RNAS
#46MMLV REVERSE TRANSCRIPTASE MUTANT
#47IMPROVED PRIME EDITORS AND METHODS OF USE
#48METHODS AND COMPOSITIONS RELATING TO A GROUP II INTRON REVERSE TRANSCRIPTASE
#49MHC Class II Protein Constructs
#50RT EDITING COMPOSITIONS AND METHODS
#51COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
#52REPROGRAMMABLE TNPB POLYPEPTIDES WITH MAZE DOMAINS AND USES THEREOF
#53Reverse Transcriptases and Related Methods
#54GENOME INSERTIONS IN CELLS
#55Continuous Multiplexed Phage Genome Engineering Using a Retron Editing Template
#56REVERSE TRANSCRIPTASE VARIANTS
#57HYBRID CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#58METHOD FOR PREDICTING OFF-TARGET WHICH CAN OCCUR IN PROCESS OF EDITING GENOME BY USING PRIME EDITING SYSTEM
#59Production of reverse transcribed DNA (RT-DNA) using a retron reverse transcriptase from exogenous RNA
#60RT-DNA Fidelity and Retron Genome Editing
#61RECOMBINANT REVERSE TRANSCRIPTASE WITH IMPROVED PROCESSIVITY
#62DNA Polymerases and Related Methods
#63REVERSE TRANSCRIPTASE VARIANTS
#64GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B
#65FUSION PROTEINS AND USES THEREOF FOR PRECISION EDITING
#66MUTANT REVERSE TRANSCRIPTASE WITH INCREASED THERMAL STABILITY AS WELL AS PRODUCTS, METHODS AND USES INVOLVING THE SAME
#67TELOMERASE REVERSE TRANSCRIPTASE THERAPY FOR KIDNEY FIBROSIS AND NON-HUMAN ANIMALS THEREOF
#68COMPOSITIONS, SYSTEMS, AND METHODS FOR PRIME EDITING
#69METHODS FOR PROCESSING NUCLEIC ACID SAMPLES
#70COMPOSITIONS AND METHODS RELATED TO MODIFICATION AND DETECTION OF PSEUDOURIDINE AND 5-HYDROXYMETHYLCYTOSINE
#71CONSENSUS SEQUENCE OF THE ANTIGEN TELOMERASE AND THE USE THEREOF IN PREVENTIVE AND THERAPEUTIC VACCINATION
#72MODULAR BETARETROVIRUS RECEPTOR ATTACHMENT AND CELL ENTRY PROTEINS
#73ORGANELLE GENOME MODIFICATION USING POLYNUCLEOTIDE GUIDED ENDONUCLEASE
#74CIRCULAR PERMUTANTS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF
#75TARGET NUCLEIC ACID DETECTION METHOD BASED ON PRIMER-ENZYME INTEGRATED PELLET
#76METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#77FUSION PROTEINS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF
#78METHODS AND SYSTEMS FOR SEQUENCING POLYNUCLEOTIDES
#79METHODS AND SYSTEMS FOR SEQUENCING POLYNUCLEOTIDES
#80EVOLVED CAS14A1 VARIANTS, COMPOSITIONS, AND METHODS OF MAKING AND USING SAME IN GENOME EDITING
#81HYBRID REVERSE TRANSCRIPTASES
#82RECOMBINANT TERT-ENCODING VIRAL GENOMES AND VECTORS
#83PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMYELINATING DISEASES CONTAINING SUPERNATANT OF IMMORTALIZED MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL PREPARATION CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT
#84SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE)
#85COMPOSITIONS FOR INCREASING POLYPEPTIDE STABILITY AND ACTIVITY, AND RELATED METHODS
#86METHODS AND SYSTEMS FOR CORRECTING MUTATIONS IN PRPH2
#87SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME
#88REVERSE TRANSCRIPTASE HAVING EXCELLENT THERMAL STABILITY
#89POLYMERASE ENZYME
#90SYNTHETIC REVERSE TRANSCRIPTASES AND USES THEREOF
#91Co-Delivery of a Gene Editor Construct and a Donor Template
#92Multicomponent systems for site-specific genome modifications
#93INOT1824 TRANSGENIC MAIZE
#94TARGETED GENOMIC BARCODING FOR TRACKING OF EDITING EVENTS
#95Precise Genome Editing Using Retrons
#96TRACKABLE NUCLEIC ACID-GUIDED EDITING
#97Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
#98OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME
#99IMPROVED CRISPR PRIME EDITORS
#100TARGETED RETROVIRAL INTEGRATION FOR TREATMENT OF GENETIC DISORDERS
#101METHODS AND COMPOSITIONS FOR EDITING A GENOME WITH PRIME EDITING AND A RECOMBINASE
#102IMPROVED PRIME EDITING SYSTEM EFFICIENCY WITH CIS-ACTING REGULATORY ELEMENTS
#103METHODS FOR BIAS-FREE QUANTIFICATION OF RNA
#104TRANSPOSOME ENABLED DNA/RNA-SEQUENCING (TED RNA-SEQ)
#105ENHANCED PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS SYSTEM USING A FUSION PROTEIN OF PRIME EDITOR PROTEIN AND PA01 INTEGRASE
#106EFFECTOR PROTEINS AND USES THEREOF
#107Improved Prime Editing System
#108RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS FOR IMPROVED PERFORMANCE
#109SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES
#110Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy
#111MTOR -TARGETED MODIFICATION AND USES THEREOF
#112COMPOSITION INCLUDING PROBIOTICS FOR TELOMERASE PRODUCTION
#113METHODS AND SYSTEMS FOR MODIFYING THE CRUMBS HOMOLOGUE-1 (CRB1) GENE
#114MESENCHYMAL STEM CELL LINE
#115METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#116High Throughput Reaction Assembly
#117SAMPLE PREPARATION METHODS, SYSTEMS AND COMPOSITIONS
#118Organelle genome modification using polynucleotide guided endonuclease
#119An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase
#120SYSTEMS, COMPOSITIONS, AND METHODS INVOLVING RETROTRANSPOSONS AND FUNCTIONAL FRAGMENTS THEREOF
#121METHOD FOR IMMORTALISING VESICLE-SECRETING CELLS
#122COMPOUNDS, COMPOSITIONS, METHODS, AND KITS RELATING TO TELOMERE EXTENSION
#123ENGINEERED PROTEINS AND METHODS OF USE THEREOF
#124HIGH TEMPERATURE RESISTANT REVERSE TRANSCRIPTASE MUTANTS AND USE THEREOF
#125METHODS AND COMPOSITIONS FOR MODULATING A GENOME
#126RNase Inhibitors
#127PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF
#128LTR TRANSPOSON COMPOSITIONS AND METHODS
#129PE-STOP Gene Editing System and Gene Knockout Method and Application
#130METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY
#131PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION
#132Engineered reverse transcriptase enzymes with enhanced enzymatic activity in nanoliter reaction
#133ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME
#134PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL
#135RNase Inhibitors
#136OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME
#137Methods of cDNA preparation
#138TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST
#139GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF
#140Anti-inflammatory peptides and composition comprising the same
#141SERPINA-MODULATING COMPOSITIONS AND METHODS
#142GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE
#143Cancer Vaccines and Methods of Treatment Using The Same
#144Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#145Methods and compositions for modulating a genome
#146TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#147Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#148METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
#149Compositions and methods for preparing capped mRNA
#150IMMORTALIZED CELL LINE FOR ENGINEERED SYNTHETIC LEATHER
#151Small type II-D Cas proteins and methods of use thereof
#152SPLIT PRIME EDITING PLATFORMS
#153Methods and compositions for modulating a genome
#154Modified reverse transcriptases
#155Mutant polymerases and uses thereof
#156PRIME EDITING USING HIV REVERSE TRANSCRIPTASE AND CAS9 OR VARIANT THEREOF
#157RECOMBINANT PROTEINS WITH INCREASED SOLUBILITY AND STABILITY
#158Methods and compositions for modulating a genome
#159Methods and compositions for modulating a genome
#160Anti-inflammatory peptides and composition comprising the same
#161GENOMIC EDITING OF IMPROVED EFFICIENCY AND ACCURACY
#162REVERSE TRANSCRIPTION OF POLYNUCLEOTIDES COMPRISING UNNATURAL NUCLEOTIDES
#163METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#164ENGINEERED THERMOPHILIC REVERSE TRANSCRIPTASE
#165IMMORTALIZED KERATINOCYTES, LENTIVIRUS FOR KERATINOCYTE IMMORTALIZATION, AND METHODS OF USE
#166METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#167METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#168Reverse Transcriptase and Methods of Use
#169PROTEIN CONSTRUCTS OF MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE (MMLV-RT)
#170SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF
#171Site-Specific Gene Modifications
#172METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#173METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#174Methods and compositions for prime editing nucleotide sequences
#175INACTIVE TELOMERASE, ADENOVIRUS ASSOCIATED VIRUS AND ARTIFICIAL MRNA HAVING SAME AND USE THEREOF
#176METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES
#177RNA SEQUENCING METHODS
#178METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#179Anti-inflammatory peptides and composition comprising the same
#180PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT
#181Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#182TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER
#183C-TERMINAL PEPTIDE EXTENSIONS WITH INCREASED ACTIVITY
#184Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same
#185COMPOSITIONS AND METHODS FOR ENHANCING REVERSE TRANSCRIPTASE ACTIVITY AND/OR REDUCING THE INHIBITION OF REVERSE TRANSCRIPTASE
#186Reactions with non-retroviral reverse transcriptase
#187SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY
#188Mutant reverse transcriptase with increased thermal stability as well as products, methods and uses involving the same
#189RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS
#190Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#191Organelle genome modification using polynucleotide guided endonuclease
#192DISSEMINATED NEOPLASIA CELLS AND METHODS OF THEIR USE TO CONTROL INVASIVE OR PEST SPECIES
#193Methods and compositions for prime editing nucleotide sequences
#194METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
#195Methods and compositions for genomic integration
#196High throughput reaction assembly
#197METHOD FOR DETECTING TARGET RNA BY UTILIZING NICKING/EXTENSION CHAIN REACTION SYSTEM-BASED ISOTHERMAL NUCLEIC ACID AMPLIFICATION
#198METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#199METHODS OF PERFORMING RNA TEMPLATED GENOME EDITING
#200Reverse transcriptase variants
#201SYSTEM AND METHOD FOR NUCLEIC ACID LIBRARY PREPARATION VIA TEMPLATE SWITCHING MECHANISM
#202UNIVERSAL LAMP ASSAYS FOR DETECTION OF NUCLEIC ACID TARGETS
#203Glycerol-free formulations for reverse transcriptases
#204Non-LTR-retroelement reverse transcriptase and uses thereof
#205METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
#206Modified heat-resistant DNA polymerase
#207IMPROVED THERMOSTABLE VIRAL REVERSE TRANSCRIPTASE
#208COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
#209METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES
#210Anti-inflammatory peptides and composition comprising the same
#211CRISPR EFFECTOR SYSTEM BASED CORONAVIRUS DIAGNOSTICS
#212Oligonucleotide compositions and methods of making the same
#213IMMORTALIZED MYOBLAST CELL LINES AND USES THEREOF
#214SYSTEMS AND METHODS FOR GENE THERAPY VIA ADMINISTRATION OF GENETICALLY MODIFIED VIRAL VECTORS
#215FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#216Methods for processing nucleic acid samples
#217Engineered polymerases for improved sequencing
#218Pharmaceutical Compositions Comprising Integration-Promoting Peptides
#219Sample preparation methods, systems and compositions
#220Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)
#221COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF ALLELES
#222Methods of Cell Renewal
#223SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE)
#224TELOMERASE-CONTAINING EXOSOMES FOR TREATMENT OF DISEASES ASSOCIATED WITH AGING AND AGE-RELATED ORGAN DYSFUNCTION
#225Reverse Transcriptase Mutants with Increased Activity and Thermostability
#226Compositions for increasing polypeptide stability and activity, and related methods
#227Poly(A)-ClickSeq Click-Chemistry for Next Generation 3-End Sequencing Without RNA Enrichment or Fragmentation
#228Anti-inflammatory peptides and composition comprising the same
#229Synthetic reverse transcriptases and uses thereof
#230Method for detecting target RNA by utilizing nicking/extension chain reaction system-based isothermal nucleic acid amplification
#231Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#232Mutant polymerases and uses thereof
#233ENGINEERED LONG INTERSPERSED ELEMENT (LINE) TRANSPOSONS AND METHODS OF USE
#234Reverse transcriptase with increased enzyme activity and application thereof
#235Crispr effector system based coronavirus diagnostics
#236Rapid diagnostics
#237Type V CRISPR-Cas systems and use thereof
#238REVERSE TRANSCRIPTASE SEQUENCE OF MARINE BACTERIOPHAGE AND USE THEREOF
#239Heat-resistant reverse transcriptase mutant
#240Cancer vaccines and methods of treatment using the same
#241TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#242MODIFIED HEAT-RESISTANT DNA POLYMERASE
#243TELOMERASE HOLOENZYME COMPLEX AND METHODS OF USE THEREOF
#244Anti-inflammatory peptides and composition comprising the same
#245TRANSPOSOME ENABLED DNA/RNA-SEQUENCING (TED RNA-SEQ)
#246Methods for producing modified reverse transcriptases
#247METHODS FOR TAGGING AND AMPLIFYING RNA TEMPLATE MOLECULES FOR PREPARING SEQUENCING LIBRARIES
#248METHODS FOR ADDING ADAPTERS TO NUCLEIC ACIDS AND COMPOSITIONS FOR PRACTICING THE SAME
#249Reverse transcriptase and methods of use
#250RNA sequencing methods
#251RNA sequencing methods
#252COMPOSITIONS AND METHODS FOR RNA-TEMPLATED EDITING IN PLANTS
#253Reverse transcriptase for nucleic acid sequencing
#254BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF
#255MMLV REVERSE TRANSCRIPTASE VARIANTS
#256DNA POLYMERASES
#257Anti-inflammatory peptides and composition comprising the same
#258Recombinant measles vaccine expressing hTERT
#259ORGANELLE GENOME MODIFICATION USING POLYNUCLEOTIDE GUIDED ENDONUCLEASE
#260Hybrid reverse transcriptases
#261RNA sequencing methods
#262Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same
#263Compositions and methods for enhancing reverse transcriptase activity and/or reducing the inhibition of reverse transcriptase
#264Sample preparation methods, systems and compositions
#265SELF-DIVERSIFYING SYSTEMS AND METHODS OF USE THEREOF
#266ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY
#267Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#268System and method for nucleic acid library preparation via template switching mechanism
#269Compounds, compositions, methods, and kits relating to telomere extension
#270Non-LTR-retroelement reverse transcriptase and uses thereof
#271Glycerol-free formulations for reverse transcriptases
#272Compositions and methods for genomic DNA and gene expression analysis in single cells
#273Compounds, compositions, methods, and kits relating to telomere extension
#274Compounds, compositions, methods, and kits relating to telomere extension
#275Anti-inflammatory peptides and composition comprising same
#276Compositions for increasing polypeptide stability and activity, and related methods
#277ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME
#278Telomerase polypeptide vaccine for treating cancer
#279Engineered polymerases for improved sequencing
#280Engineered polymerases for improved sequencing
#281Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient
#282Mutant reverse transcriptase with increased thermal stability as well as products, methods and uses involving the same
#283TERT immunogenic compositions and methods of treatment using the same
#284METHOD FOR DETECTING KNOWN NUCLEOTIDE MODIFICATIONS IN AN RNA
#285Synthetic reverse transcriptases and uses thereof
#286METHODS OF DEPLETING OR ISOLATING TARGET RNA FROM A NUCLEIC ACID SAMPLE
#287High Throughput Reaction Assembly
#288Poly(A)-ClickSeq click-chemistry for next generation 3-end sequencing without RNA enrichment or fragmentation
#289Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
#290REVERSE TRANSCRIPTASE MIXTURES WITH IMPROVED STORAGE STABILITY
#291Anti-inflammatory peptides and compositions comprising the same
#292Methods for measuring RNA translation rates
#293IMMORTALISED CHICKEN EMBRYONIC EPITHELIAL KIDNEY CELLS
#294Nucleic acid modifying enzymes
#295Methods for processing nucleic acid samples
#296Methods for processing nucleic acid samples
#297Methods for processing nucleic acid samples
#298Cancer vaccines and methods of treatment using the same
#299Peptide having anti-viral effect and composition containing same
#300Anti-inflammatory peptides and composition comprising the same